Epictal 750mg Tablet contains Levetiracetam, an antiepileptic agent indicated for the treatment of partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in adults and pediatric patients. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, thereby stabilizing neuronal activity and reducing seizure frequency. Epictal is typically prescribed as adjunctive therapy but may also be used as monotherapy depending on clinical judgment. The recommended dosage varies based on patient age, renal function, and seizure type, with careful titration to minimize adverse effects. Common side effects include somnolence, dizziness, fatigue, and behavioral changes such as irritability or mood swings. Caution is advised in patients with renal impairment, and dose adjustments may be necessary. Epictal should be used under strict medical supervision, with regular monitoring for efficacy and tolerability. Abrupt discontinuation is discouraged due to the risk of increased seizure frequency. This medication is contraindicated in patients with known hypersensitivity to Levetiracetam or any excipients. Epictal 750mg Tablet offers a well-tolerated and effective option for seizure management, improving patient quality of life when integrated into a comprehensive epilepsy treatment plan.